Home
ABOUT GENELUX
BOARD OF DIRECTORS
MANAGEMENT TEAM
ADVISORY BOARD
TECHNOLOGY
ATTACKING CANCER
Clinical Therapies
CLINICAL TRIALS
Pipeline
Expanded Access Policy
PRESS & PUBLICATIONS
PRESS RELEASES
VIEW MORE RELEASES
CLINICAL PUBLICATIONS
PRE-CLINICAL PUBLICATIONS
CONTACT
Clinical Publications
Oncolytic Vaccinia (Olvi-Vec) Primed Immunochemotherapy in Platinum-Resistant/Refractory Ovarian Cancer
https://genelux.com/wp-content/uploads/2020/09/Genelux-Olvi-Vec-Trial.mp4